Moleculin Biotech, Inc.
MBRX
$2.41
-$0.06-2.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.85M | 15.55M | -35.04M | -7.64M | -5.90M |
| Total Depreciation and Amortization | 8.00K | 9.00K | 22.00K | 28.00K | 31.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.60M | -22.81M | 29.49M | 2.37M | 603.00K |
| Change in Net Operating Assets | 1.13M | 1.88M | -1.70M | -335.00K | 706.00K |
| Cash from Operations | -6.11M | -5.37M | -7.22M | -5.58M | -4.56M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.61M | 7.50M | 6.38M | 5.42M | 8.00M |
| Repurchase of Common Stock | -- | -8.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.61M | 7.49M | 6.38M | 5.42M | 8.00M |
| Foreign Exchange rate Adjustments | -62.00K | 54.00K | -6.00K | 0.00 | 3.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.44M | 2.18M | -854.00K | -159.00K | 3.44M |